Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Agios Pharmaceuticals

    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -389 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
    Company Website
    AGIOS PHARMACEUTICALS INC

  2. Pharvaris N.V.

    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Netherlands
    Yahoo @ Nasdaq
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
    Company Website
    PHARVARIS N.V.

  3. Protagonist Therapeutics

    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    27 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -127 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Stuttgart
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

    Company Website
    PROTAGONIST THERAPEUTICS

  4. Sage Therapeutics

    World Rank (Jan-05-2024)
    7,382
    Market Cap (Jan-05-2024)
    1.301 Billion USD
    World Rank (Jul-30-2023)
    5,572
    Market Cap (Jul-30-2023)
    2.089 Billion USD
    World Rank (Dec-25-2022)
    4,977
    Market Cap (Dec-25-2022)
    2.288 Billion USD
    World Rank (Jan-07-2022)
    5,501
    Market Cap (Jan-07-2022)
    2.48 Billion USD
    Annual Revenue in USD
    8 Million USD
    Annual Operating Income in USD
    -546 Million USD
    Annual Net Income in USD
    -532 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio Pharmaceutical company with headquarters is in Massachusetts, USA.
    Company Website
    SAGE THERAPEUTICS INC

  5. Deciphera Pharmaceuticals

    World Rank (Jan-05-2024)
    7,448
    Market Cap (Jan-05-2024)
    1.281 Billion USD
    World Rank (Jul-30-2023)
    8,471
    Market Cap (Jul-30-2023)
    1.056 Billion USD
    World Rank (Dec-25-2022)
    7,863
    Market Cap (Dec-25-2022)
    1.116 Billion USD
    World Rank (Jan-07-2022)
    13,040
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    134 Million USD
    Annual Operating Income in USD
    -182 Million USD
    Annual Net Income in USD
    -178 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Deciphera Pharmaceuticals is a Healthcare company. The company developing novel drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. The headquarters is in USA.
    Company Website
    DECIPHERA PHARMACEUTICALS

  6. Akero Therapeutics

    World Rank (Jan-05-2024)
    7,478
    Market Cap (Jan-05-2024)
    1.272 Billion USD
    World Rank (Jul-30-2023)
    5,174
    Market Cap (Jul-30-2023)
    2.349 Billion USD
    World Rank (Dec-25-2022)
    4,983
    Market Cap (Dec-25-2022)
    2.284 Billion USD
    World Rank (Jan-07-2022)
    11,418
    Market Cap (Jan-07-2022)
    0.70 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -115 Million USD
    Annual Net Income in USD
    -112 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Akero Therapeutics is a Biotechnology company focused on reverse the course of serious metabolic diseases and transform patients. The headquarters is in USA.
    Company Website
    AKERO THERAPEUTICS

  7. Day One Biopharmaceuticals Inc.

    World Rank (Jan-05-2024)
    7,553
    Market Cap (Jan-05-2024)
    1.246 Billion USD
    World Rank (Jul-30-2023)
    8,115
    Market Cap (Jul-30-2023)
    1.136 Billion USD
    World Rank (Dec-25-2022)
    6,738
    Market Cap (Dec-25-2022)
    1.431 Billion USD
    World Rank (Jan-07-2022)
    9,477
    Market Cap (Jan-07-2022)
    0.99 Billion USD
    Annual Operating Income in USD
    -142 Million USD
    Annual Net Income in USD
    -142 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Day One Biopharmaceuticals Inc is a clinical stage biopharmaceutical company developing targeted therapies for patients of all ages with life threatening diseases. The headquarters is in USA.
    Company Website
    DAY ONE BIOPHARMACEUTICALS, INC.

  8. Ligand Pharmaceuticals

    World Rank (Jan-05-2024)
    7,621
    Market Cap (Jan-05-2024)
    1.227 Billion USD
    World Rank (Jul-30-2023)
    7,940
    Market Cap (Jul-30-2023)
    1.175 Billion USD
    World Rank (Dec-25-2022)
    5,769
    Market Cap (Dec-25-2022)
    1.822 Billion USD
    World Rank (Jan-07-2022)
    5,576
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Annual Revenue in USD
    196 Million USD
    Annual Operating Income in USD
    3 Million USD
    Annual Net Income in USD
    -33 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ligand Pharmaceuticals is a Biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It is providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The headquarters is in USA.
    Company Website
    LIGAND PHARMACEUTICALS INCORPORATED

  9. Aurinia Pharmaceuticals

    World Rank (Jan-05-2024)
    7,666
    Market Cap (Jan-05-2024)
    1.213 Billion USD
    World Rank (Jul-30-2023)
    6,232
    Market Cap (Jul-30-2023)
    1.755 Billion USD
    World Rank (Dec-25-2022)
    10,850
    Market Cap (Dec-25-2022)
    0.644 Billion USD
    World Rank (Jan-07-2022)
    5,556
    Market Cap (Jan-07-2022)
    2.44 Billion USD
    Annual Revenue in USD
    35 Million USD
    Annual Net Income in USD
    -138 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Company Profile
    Aurinia Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company developing in voclosporin, an investigational therapy for the treatment of lupus nephritis and other proteinuric diseases. The headquarters is in Canada.
    Company Website
    AURINIA PHARMACEUTICALS

  10. ANI Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    7,914
    Market Cap (Jan-05-2024)
    1.149 Billion USD
    World Rank (Jul-30-2023)
    8,477
    Market Cap (Jul-30-2023)
    1.055 Billion USD
    World Rank (Dec-25-2022)
    10,448
    Market Cap (Dec-25-2022)
    0.689 Billion USD
    World Rank (Jan-07-2022)
    11,253
    Market Cap (Jan-07-2022)
    0.73 Billion USD
    Annual Revenue in USD
    316 Million USD
    Annual Operating Income in USD
    -26 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Stuttgart
    Company Profile
    ANI Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is focused on delivering value to customers by developing, manufacturing and marketing high quality branded and generic prescription pharmaceuticals. The company annual revenue is 206.5 million USD and 338 employees as on 2019. The headquarters is in USA.
    Company Website
    ANI PHARMACEUTICALS INC

Share